Why Oppenheimer Global fund is focusing on biotech as rates rise

NEW YORK (Reuters) - The recent volatility in the global stock market may make some investors feel queasy, but it is providing a buying opportunity in biotechnology stocks.

from Reuters: Money http://ift.tt/2CMRsUy
via IFTTT